Of the tracked stories, 2 of 2 also mention Zacks Research, the most common co-covered peer. That works out to roughly 0.3 stories per week across a 48-day span. Each story carries 2 original sources on average, compared with 3 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Millennium Management LLC
Of the tracked stories, 2 of 2 also mention Zacks Research, the most common co-covered peer. That works out to roughly 0.3 stories per week across a 48-day span. Each story carries 2 original sources on average, compared with 3 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.1 for that window. earnings accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Millennium Management LLC appears in 2 tracked Finance stories published from June 23, 2026 through August 9, 2026.
Stories tracked
2
Per week
0.3
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 835 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Millennium Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Collegium Pharmaceutical delivered an 11.6% EPS beat and modest revenue beat, lifting shares to $29.47. High ROE and institutional accumulation offset by high leverage and mixed analyst ratings create a nuanced investment case.
Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm.